Miconal (Miconazole Nitrate)

Miconazole nitrate inhibits the fungal enzyme lanosterol 14α‑demethylase, which is essential for ergosterol synthesis. Without ergosterol, the fungal cell membrane becomes defective, leading to increased permeability and cell death. This targeted action reduces the fungal load on the skin.

The dosage of Miconal is determined by the prescribing healthcare professional based on the infection type, severity, and patient age. The prescriber will specify the amount to apply, frequency, and duration of treatment on the product label or prescription.

Safety data for topical miconazole nitrate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Miconal.

To place an order, submit an enquiry on the Miconal product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Miconal (miconazole nitrate) offers broad‑spectrum activity against dermatophytes and yeasts, similar to other imidazole or allylamine creams. Compared with older agents like clotrimazole, miconazole often provides comparable efficacy with a favorable safety profile, but choice of therapy should be guided by clinician assessment of infection type and patient factors.

Miconal should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, direct sunlight and excessive heat to maintain product stability.

Miconal is applied topically to the affected skin area. Clean and dry the area before use, then spread a thin layer of the cream or ointment as directed by the prescriber, typically twice daily, for the prescribed duration.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, extensive contact dermatitis, and rare severe skin conditions like Stevens‑Johnson syndrome. Patients should stop use and seek immediate medical attention if they experience swelling, blistering, or widespread rash.

Miconal should not be used by individuals with known hypersensitivity to miconazole nitrate or any component of the formulation. It is also contraindicated on broken, severely inflamed skin, and should be avoided in the eyes, ears, or mucous membranes.